Skip to main content
. Author manuscript; available in PMC: 2013 Oct 9.
Published in final edited form as: Biol Blood Marrow Transplant. 2009 Sep;15(9):1108–1115. doi: 10.1016/j.bbmt.2009.05.015

Table 5.

Results from the Multivariate Analysis of Factors Associated with low LC30

RH 95% CI P-Value
CML 0.74 0.34-0.78 0.001
Prophylaxis with G-CSF 0.81 0.68-0.97 0.02
Acute GVHD II-IV (before day 30) 0.84 0.70-1.00 0.05

RH indicates relative hazard; CI, confidence interval; G-CSF, granulocyte-colony stimulating factor; CML, chronic myelogenous leukemia; LC30, day 30 absolute lymphocyte count.